Stocks
ANI Pharmaceuticals (ANIP) EV/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 246.3 | 35.6 | 9.92 | 24.4 | 7.83 | 5.59 | ||
| Changes by years, y/y, % | +1 263% | -86% | -72% | +146% | -68% | -15.4% | |||
ANI Pharmaceuticals. EV/EBITDA
ANI Pharmaceuticals. EV/EBITDA, changes, %
ANI Pharmaceuticals (ANIP) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EV/EBITDA | ? | 26.6 | 19.0 | 11.6 | 7.19 | 6.86 | 5.59 | |
| Changes by years, y/y, % | +147% | +75% | -50% | -71% | -74% | |||
| Changes by quarters, q/q, % | +9% | -29% | -39% | -38% | -5% | |||
